Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse
| Image |  |
|---|---|
| Description | scientific article published on 20 November 2018 |
| Author/s |
author: Kwee L Yong Oliver C Cohen Rakesh Popat |
| Publication date | November 20, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |